mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.05 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.05 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |